In order to establish the dose of theophylline as a bronchodilator, plasma theophylline levels and respiratory impedance were monitored serially after the intravenous administration of theophylline in 14 patients with bronchial asthma.
Although the bronchodilator effect of theophylline was amply documented, most of the previous reports simply demonstrated the improvement of pulmonary-function at a plasma theophylline concentration plateau. It should be pointed out that miscellaneous factors other than drug effects might interfere with observation when forced expiration is repeated and it took a long time to attain and keep a certain plasma level. In addition, it should be remembered that the bronchodilator effect could be observed only in the bronchoconstrictive state. In the present study the plasma theophylline level changed more rapidly, and the observation was made only in those patients who had kept bronchoconstrictive tendency and returned to an asthmatic state in association with the elimination of theophylline.
Two different procedures were employed. In procedure (A), 250mg of aminophylline (equivalent to 200mg of theophylline) was infused intravenously into each of the 7 subjects for ten minutes, and in procedure (B), into each of the other 7 subjects for 120 minutes. The plasma theophylline concentrations were determined by cation-exchange high-pressure liquid chromatography, and the respiratory impedance was measured by the air oscillation method (MZR-4000, Nihonkohden Ltd.).
The following results were obtained:
1) The increase in the plasma concentration of theophylline after 250mg of intravenous aminophylline administration was 14.7±3.7mcg/ml in procedure (A), and 8.7±1.5mcg/ml in procedure (B) respectively (Mean±S.D.). There were rough inverse correlations between the increase of plasma theophylline level and body weight and body surface area.
2) In procedure (A), the respiratory impedance was reduced to approximately 50% of the previous value at 30min after infusion when the plasma theophylline concentration was 9.1±2.9mcg/ml. In procedure (B), a similar reduction was observed at 120min after the start of infusion, when the concentration was 10.2±2.6mcg/ml. These effects were unchanged at 240min in both procedures.
3) There was a dose-response relationship between the plasma theophylline level and the respiratory impedance during the whole course in procedure (B) or at 30min and later in procedure (A).
4) During the course of plasma theophylline degradation, the respiratory impedance was reduced or unchanged when the plasma theophylline level exceeded 8mcg/ml but it was variable, ranging from 6 to 8mcg/ml. It was not reduced at below 6mcg/ml.
5) The respiratory impedance was not reduced to lower than 70% of the previous value until the plasma theophylline level exceeded 8mcg/ml.
View full abstract